Selective loss of cholinergic receptors following unilateral intracortical injection of volkensin

Experimental Neurology

Volumn 147, Issue 1, 1997, Pages 183-191

  Chessell, I P ^a,d   Pearson, R C A ^b   Heath, P R ^b   Bowen, D M ^a   Francis, P T ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; RICIN; VOLKENSIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN INJURY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; QUANTITATIVE ASSAY; RAT;

EID: 0031239822     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6595     Document Type: Article

References (50)

1. Atack J. R., Wenk G. L., Wagster M. V., Kellar K. J., Whitehouse P. J., Rapoport S. I. Bilateral changes in neocortical 3H pirenzepine and 3H oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: An autoradiographic study. Brain Res. 483:1989;367-372.
2. 18. Neurosci. Lett. 121:1991;183-186.
3. Bowen D. M., Francis P. T., Pangalos M. N., Chessell I. P. Neurotransmitter receptors of rat cortical pyramidal neurones: Implications forin vivo. J. Reprod. Fertil. 46:1993;131-143.
4. Brann M. R., Buckley N. J., Bonner T. I. The striatum and cerebral cortex express different muscarinic receptor mRNA. FEBS Lett. 230:1988;90-94.
5. Bravo H., Karten H. J. Pyramidal neurones of the rat cerebral cortex, immunoreactive to nicotinic acetylcholine receptors, project mainly to subcortical targets. J. Comp. Neurol. 320:1992;62-68.
6. Brion J., Smith C., Couck A., Gallo J., Anderton B. H. Developmental changes in tau phosphorylation: Fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J. Neurochem. 61:1993;2071-2080.
7. Buckley N. J., Bonner T. I., Brann M. R. Localisation of a family of muscarinic receptor mRNAs in rat brain. J. Neurosci. 8:1988;4646-4652.
8. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski P., Jaffe E. A., Gandy S. E., Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA. 89:1992;10075-10078.
9. Caporaso G. L., Gandy S. E., Buxbaum J. D., Ramabhadran T. V., Greengard P. Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 89:1992;3055-3059.
10. Chessell I. P., Francis P. T., Heath P. R., Pearson R. C. A., Bowen D. M. Effect of entorhinal injection of volkensin on the structure and neurotransmitter receptors of the hippocampus. Br. J. Pharmacol. 108:1993;51.
11. 1. Brain Res. 632:1993;86-94.
12. Contestabile A., Stirpe F. Ribosome-inactivating proteins from plants as agents for suicide transport and immunolesioning in the nervous system. Eur. J. Neurosci. 5:1993;1292-1301.
13. Contestibile A., Fasolo A., Virgli M., Migani P., Villani L., Stirpe F. Anatomical and neurochemical evidence for suicide transport of a toxic lectin, volkensin, injected in the rat dorsal hippocampus. Brain Res. 537:1990;279-286.
14. Davis D. R., Brion J., Gallo J., Hanger D. P., Ladhani K., Lewis C., Miller C. C. J., Rupniak T., Smith C., Anderton B. H. The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and β-amyloid in primary rat cortical neuronal cultures. Biochem. J. 309:1995;941-949.
15. 2. Science. 231:1986;258-261.
16. 1A2. J. Pharmacol. Exp. Ther. 261:1992;1273-1281.
17. Francis P. T., Chessell I. P., Stephens P. H., Pangalos M. N., Procter A. W., Bowen D. M. Suicide-transport agents model an aspect of Alzheimer's pathology: Therapeutic implications. Alzheimer's Disease: Advances in Clinical and Basic Research. 1993;Wiley, Chichester. p. 489-495.
18. Francis P. T., Sims N. R., Procter A. W., Bowen D. M. Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: Investigative and therapeutic perspectives. J. Neurochem. 60:1993;1589-1604.
19. Goedert M., Spillantini M. G., Cairns N. J., Crowther R. A. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron. 8:1992;159-168.
20. Goode N., Hughes K., Woodgett J. R., Parker P. J. Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J. Biol. Chem. 267:1992;16878-16882.
21. Hartig P. R., Lever J. R. Serotonin receptors. Frost J. J., Wagner H. N. Quantitative imaging: Neurotransmitters and enzymes. 1990;153-164 Raven, New York.
22. Heath P. R., Chessell I. P., Sanders M. W., Francis P. T., Bowen D. M., Pearson R. C. A. Neuronal degeneration by suicide transport following injection of volkensin into rat cerebral cortex. Exp. Neurol. 1997.
23. Heimer L., Alheid G. F., Zaborszky L. Basal ganglia. Paxinos G. The Rat Nervous System. 1985;37-86 Academic Press, Sydney.
24. Heinemann S., Boulter J., Connolly J., Deneris E., Duvoisin R., Hartley M., Hermans-Borgmeyer I., Hollmann M., O'Shea-Greenfield A., Papke R., Rogers S., Patrick J. The nicotinic receptor genes. Clin. Neuropharmacol. (Suppl.). 14:1991;S45-S61.
25. Jones E. G. Laminar distribution of cortical efferent cells. Peters A., Jones E. G. Cerebral Cortex: Vol. 1, Cellular Components of the Cerebral Cortex. 1984;521-553 Plenum, New York.
26. Kisvarday Z. F., Martin K. A. C., Freund T. F., Magloczky Z., Whitteridge D., Somogyi P. Synaptic targets of HRP-filled layer III pyramidal cells in the cat striate cortex. Exp. Brain Res. 64:1986;541-552.
27. MacLean P. D. Fiber systems of the forebrain. Paxinos G. The Rat Nervous System. 1994;417-440 Academic Press, London.
28. Maziere B., Maziere M. Where have we got to with neuroreceptor mapping of the human brain. Eur. J. Nuclear Med. 16:1990;817-835.
29. McCormick D. A., Williamson A. Convergence and divergence of neurotransmitter action in human cerebral cortex. Proc. Natl. Acad. Sci. USA. 86:1989;8098-8102.
30. Middlemiss D. N., Palmer A. M., Edel N., Bowen D. M. Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin in normal and Alzheimer brain. J. Neurochem. 46:1986;993-996.
31. Miyai I., Ueno S., Yorifuji S., Fujimura H., Tarui S. Alterations in neocortical expression of nicotinic acetylcholine receptor mRNAs encoding the enzymes glutaminase, aspartate aminotransferase and glutamic acid decarboxylase in rat brain. J. Neural Transm. 82:1990;79-91.
32. Newcombe J., Woodroofe M. N., Cuzner M. L. Distribution of glial fibrillary acidic protein in gliosed human white matter. J. Neurochem. 47:1986;1713-1719.
33. Nitsch R. M., Slack B. E., Wurtman R. J., Growdon J. H. Release of Alzheimer amyloid precursor stimulated by activation of muscarinic acetylcholine receptors. Science. 258:1992;304-307.
34. 11. J. Neural Transm. 4:1992;79-95.
35. Pangalos M. N., Francis P. T., Middlemiss D. N., Pearson R. C. A., Bowen D. M. Selective destruction of a sub-population of cortical neurones by suicide transport of volkensin, a lectin fromAdenia volkensii. J. Neurosci. Methods. 40:1991;17-29.
36. 3. Brain Res. 596:1992;223-230.
37. 1. J. Neurochem. 58:1992;941-950.
38. Sahin M., Bowen W. D., Donoghue J. P. Location of nicotinic and muscarinic cholinergic and μ-opioid receptors inrat cerebral cortex: Evidence from thalamic and cortical lesions. Brain Res. 579:1992;135-147.
39. Saper C. B. Organisation of cerebral cortical afferent systems in rat, I. Magnocellular basal nucleus. J. Comp. Neurol. 222:1984;313-342.
40. Sofroniew M. V., Eckenstein F., Cuello A. C. Immunohistochemistry of cholinergic neurones in the rat brain and spinal cord. Neurosci. Lett. 14:1983;S348.
41. Sofroniew M. V., Campbell P. E., Cuello A. C., Eckenstein F. Central cholinergic neurons visualized by immunohistochemical detection of choline acetyltransferase. Paxinos G. The Rat Nervous System. 1985;471-485 Academic Press, London.
42. Sofroniew M. V., Pearson R. C. A. Degeneration of cholinergic neurons in the basal nucleus following kainic orND. Brain Res. 339:1985;186-190.
43. Stirpe F., Barbieri L., Abbondanza A., Falasca A. I., Brown A. N. F., Sandvig K., Olsnes S., Pihl A. Properties of volkensin, a toxic lectin fromAdenia volkinsii. J. Biol. Chem. 260:1985;14589-14595.
44. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
45. Verhoeff N. P. L. G. Pharmacological implications for neuroreceptor imaging. Eur. J. Nuclear Med. 18:1991;482-502.
46. Wenk G. L., Rokaeus A. Basel forebrain lesions differentially alter galinin levels and acetylcholinergic receptors in the hippocampus and neocortex. Brain Res. 460:1988;17-21.
47. Wiley R. G., Blessing W. W., Reis D. J. Suicide transport: destruction of neurons by retrograde transport of ricin, abrin and modeccin. Science. 216:1982;889-890.
48. Wiley R. G., Stirpe F. Modeccin and volkensin but not abrin are effective suicide transport agents in rat CNS. Brain Res. 438:1988;145-154.
49. Young A. B., Penney J. B. Neurotransmitter receptors in Alzheimer's disease. Terry R. D., Katzman R., Bick K. L. Alzheimer Disease. 1994;293-303 Raven Press, New York.
50. Zilles K., Wree A. Cortex: Areal and laminar structure. Paxinos G. The Rat Nervous System. 1985;Academic Press, London.